Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Berkeley Nutraceuticals Projects $260 Mil. In Sales In 2004

This article was originally published in The Tan Sheet

Executive Summary

Berkeley Premium Nutraceuticals' marketing efforts will replicate the strategy of its flagship Enzyte "male enhancement" product as the firm grows its portfolio to more than 10 brands by year end, the firm says

You may also be interested in...



Enzyte Male Enhancement Program Claims Overly Enhanced

Lifekey Healthcare should discontinue performance and efficacy claims for its Enzyte Male Enhancement Program, due in part to insufficient clinical evidence of the product's performance and efficacy, the National Advertising Division says

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel